NCT06584318 Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
| NCT ID | NCT06584318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Capital Medical University |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-03-01 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer.
Eligibility Criteria
Inclusion Criteria: * Patients with colorectal cancer between ages of 18 and 65 years. * Colorectal cancer stage Ⅰ,Ⅱ. * Subjects or their legally authorized representative can provide informed consent. Exclusion Criteria: * History of cardiovascular, cerebrovascular, dermatological, and hematological diseases. * History of pulmonary, hepatic, kidney, dermatologic and hematologic diseases. * History of pregnancy, hypertension, diabetes mellitus, obesity, sleep apnea and neurological disorders. * History of substance abuse. * Participating in other drug or medical device studies. * History of organ transplantation, including allogeneic stem cell and immune cell transplantation. * Recent severe infection within 4 weeks. * Received cancer treatment, including chemotherapy and radiotherapy, within 4 weeks. * Underwent major surgery within 28 days.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06584318 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06584318 currently recruiting?
Yes, NCT06584318 is actively recruiting participants. Contact the research team at wilma0106@163.com for enrollment information.
Where is the NCT06584318 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06584318 clinical trial?
NCT06584318 is sponsored by Capital Medical University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.